Category Archives: Company News

BURNABY, British Columbia – January 27, 2015 – LED Medical Diagnostics Inc. (“LED Medical” or the “Company”), announces that, subject to TSX Venture Exchange approval, it is undertaking a non-brokered private placement of up to 10,000,000 units at an issue price of CA$0.25 per unit for gross proceeds of up to $2.5 million. Each unit

BURNABY, British Columbia – November 28, 2014 – LED Medical Diagnostics Inc. (“LED Medical” or the “Company”) today announced its financial results for the third quarter ended September 30, 2014, reported in United States dollars and in accordance with International Financial Reporting Standards (“IFRS”). The Company’s results are presented in comparison to the third quarter

Burnaby, British Columbia – Oct. 28, 2014 – LED Dental (“LED Dental” or the “Company”), a wholly owned U.S. operating subsidiary of LED Medical Diagnostics Inc. (“LED Medical”), today announced that Randolph Simmons, a leading technical specialist for dental and medical imaging companies, has joined the team. Simmons will head LED Dental’s Services Division as

BURNABY, British Columbia – October 14, 2014 – LED Medical Diagnostics Inc. (“LED Medical” or “the Company”) is pleased to announce that, as of October 1, 2014, it has renewed its exclusive international distribution agreement (outside North America) for three years with DenMat Holdings LLP (DenMat) for its VELscope® Vx product line. This agreement requires

A recent independent clinical study by seven researchers from the University of British Columbia, British Columbia Cancer Agency and Simon Fraser University, is the latest report to document the benefits of adjunctive oral examination technology. The lead researcher for the study was Denise M. Laronde RDH MSc, of the Department of Oral Biological and Medical

Announcing the 2014 VELscope Sweepstakes

Are you thinking about or have you already introduced oral mucosal disease and cancer screening to your practice? Then it may be time to introduce you to the VELscope® Vx. The technology is designed to detect dysplasia and other lesions at their earliest stages, so patients have the best chances for long term outcomes. Not only